| DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer R Matsunuma, DW Chan, BJ Kim, P Singh, A Han, AB Saltzman, C Cheng, ... Proceedings of the National Academy of Sciences 115 (51), E11978-E11987, 2018 | 44 | 2018 |
| Genetic Landscape of Male Breast Cancer FAB Campos, E Rouleau, GT Torrezan, DM Carraro, JC Casali da Rocha, ... Cancers 13 (14), 3535, 2021 | 29 | 2021 |
| Association of menopausal status, expression of progesterone receptor and Ki67 to the clinical response to neoadjuvant chemotherapy in luminal breast cancer LR da Silva, RF Vargas, JY Shinzato, SFM Derchain, S Ramalho, ... Revista Brasileira de Ginecologia e Obstetrícia/RBGO Gynecology and …, 2019 | 14 | 2019 |
| Associação de status menopausal, expressão de receptor de progesterona e de Ki67 à resposta clínica à quimioterapia neoadjuvante no câncer luminal de mama LR Silva, RF Vargas, JY Shinzato, SFM Derchain, S Ramalho, ... Revista Brasileira de Ginecologia e Obstetrícia 41 (12), 710-717, 2019 | 14* | 2019 |
| ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor–Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy T Reinert, S Ramalho, VCA de Vasconcelos, LR Silva, AER da Silva, ... Frontiers in oncology 10, 342, 2020 | 9 | 2020 |
| Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer LR da Silva, CA de Andrade, F Brenelli, S Ramalho, T Reinert, ... Breast Cancer Research and Treatment 186 (3), 753-760, 2021 | 3 | 2021 |
| Abstract P2-11-08: ESR1 mutations are not a mechanism of primary resistance to aromatase inhibitors in ER-positive breast cancer treated with neoadjuvant endocrine therapy T Reinert, S Ramalho, VCA Vasconcelos, LR Silva, AER Silva, ... Cancer Research 80 (4 Supplement), P2-11-08-P2-11-08, 2020 | | 2020 |
| ESR1 mutations are not a mechanism of primary resistance to aromatase inhibitors in ER-positive breast cancer treated with neoadjuvant endocrine therapy T Reinert, S Ramalho, VCA Vasconcelos, LR Silva, AER Silva, ... CANCER RESEARCH 80 (4), 2020 | | 2020 |
| Abstract P1-15-16: Pathological complete response rates with the addition of carboplatin to standard neoadjuvant chemotherapy in a cohort of real–world patients with triple … S Ramalho, RA Natal, C Cardoso Filho, MB Xavier, AER da Silva, ... Cancer Research 79 (4 Supplement), P1-15-16-P1-15-16, 2019 | | 2019 |
| Pathological complete response rates with the addition of carboplatin to standard neoadjuvant chemotherapy in a cohort of real-world patients with triple negative breast cancer S Ramalho, RA Natal, C Cardoso Filho, MB Xavier, AER da Silva, ... Cancer research, 2019 | | 2019 |
| Preditores de resposta à quimioterapia neoadjuvante em pacientes com carcinoma luminal de mama= Predictors of response to neoadjuvant chemotherapy in patients with luminal … LR Silva [sn], 2015 | | 2015 |
| Tomás Reinert*, Susana Ramalho 4, Vivian Castro Antunes de Vasconcelos4 LR Silva, AER da Silva, CA de Andrade, MBPL Kraft, GP Coelho, ... | | |
